Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moleculin Biotech (MBRX) Shares Issued (2016 - 2025)

Moleculin Biotech (MBRX) has 9 years of Shares Issued data on record, last reported at $1.1 million in Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to $1.1 million; the TTM value through Sep 2025 reached $1.1 million, changed N/A, while the annual FY2024 figure was $1000.0, N/A changed from the prior year.
  • Shares Issued reached $1.1 million in Q3 2025 per MBRX's latest filing, up from $6000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $74.7 million in Q1 2021 and bottomed at -$74.6 million in Q2 2021.
  • Average Shares Issued over 4 years is $107727.3, with a median of $6000.0 recorded in 2025.
  • The widest YoY moves for Shares Issued: up 587.95% in 2021, down 587.79% in 2021.
  • A 4-year view of Shares Issued shows it stood at -$74.6 million in 2021, then skyrocketed by 99.72% to -$211000.0 in 2023, then surged by 100.47% to $1000.0 in 2024, then surged by 111000.0% to $1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $1.1 million in Q3 2025, $6000.0 in Q2 2025, and $4000.0 in Q1 2025.